Its molecular pathology revealed evidence of mutations in IDH1 and TP53 (Figure 2d,e), no evidence for chromosome 1p/19q codeletion, and a KI67 labeling index of 6%, consistent with a CNS WHO grade 2 IDH-mutant astrocytoma. Here, TP53 is linked to astrocytoma (excluding glioblastoma).